Max Robotics — Global Service Robot Directory + US Certification

About

Shuanglei Li is a pioneering surgeon whose work sits at the intersection of robotic surgery and complex cardiovascular oncology. His primary research focuses on developing minimally invasive techniques for treating renal tumors with inferior vena cava (IVC) tumor thrombus—a notoriously challenging condition. Li’s major contributions include establishing the safety and efficacy of robot-assisted Level III-IV IVC thrombectomy, a procedure that traditionally requires highly invasive open surgery. His landmark 2019 paper, cited 99 times, provided the first step-by-step protocol for this approach, demonstrating its feasibility with promising 1-year outcomes. He further advanced the field by introducing an intrapericardial control technique for Level IV thrombi, which avoids the severe complications of cardiopulmonary bypass. Beyond renal oncology, Li has significantly impacted cardiac surgery, reporting a 23-year single-institution experience with primary cardiac tumors (26 citations) and comparing robotic versus open chest surgery for heart tumors. His comparative study of robotically assisted coronary artery bypass grafting versus drug-eluting stents for left anterior descending disease (8 citations) highlights his commitment to evidence-based, patient-centered innovation. With a growing body of work exceeding 150 total citations, Shuanglei Li is a leading voice in the robotic revolution of complex oncologic and cardiac surgery.